About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Costliest Medicine Received US Regulators Approval

by Ramya Rachamanti on May 27, 2019 at 7:17 PM
Font : A-A+

Costliest Medicine Received US Regulators Approval

US FDA has approved the most expensive medicine named Zolgensma sold by the Novartis at $2.125 million (around Rs. 14cr) to treat spinal muscular atrophy (SMA), a fatal spinal disease that kills nearly everyone within few years, for children aged below two after doing a genetic test.

The drug targets a defective gene that weakens a child's muscles that they become unable to move, and finally unable to swallow or breathe. It occurs in about 400 babies born in the US every year. The therapy is a one-time infusion that takes about an hour.

Advertisement


Zolgensma acts by supplying a fresh copy of the faulty gene, allowing the nerve cells to start producing the needed protein that allows the baby to develop normally.

Babies with the most severe form of the disease who got Zolgensma within six months of birth had limited muscle problems. They stopped losing muscle control, but the medicine can't reverse the damage already done.
Advertisement

Early diagnosis and early treatment is crucial, so Novartis has been working with states to get genetic testing for newborns required at birth. Most states were expected to have that requirement by next year.

Side effects of this new drug includes vomiting and potential liver damage. Patients must be monitored thoroughly for the first few months after treatment.

One more medicine for the disease approved is Spinraza to be given once every four months, sold by Biogen which charges $750,000 for the first year and then $350,000 per year after that.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Can Adjusting Fatty Acid Intake Improve Mood in Bipolar Disorder Patients?
Insulin Resistance Doubles the Risk of Major Depressive Disorder
Emotional Healing
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity 

Recommended Reading
New Method to Deliver Nusinersen Drug to Patients with Spinal Muscular Atrophy
New method has been found to deliver nusinersen drug to treat patients with spinal muscular ......
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use